Literature DB >> 31289356

Multifocal electroretinogram findings in sickle cell maculopathy.

Laurence Beral1,2, Marc Romana2,3, Nathalie Lemonne4, Yoann Garnier2,3, Marie Billaud4, Malik Acomat1, Coralie Zorobabel1, Maryse Etienne-Julan4, Thierry David1,5, Philippe Connes6,7,8,9.   

Abstract

BACKGROUND: The aim of the present work was to describe and compare multifocal electroretinogram findings (mfERG) between patients with sickle cell disease (SCD) without clinical sign of maculopathy and controls (HbAA).
METHODS: Both HbSS (homozygous SCD) and HbSC (compound heterozygous SCD) patients, the two most frequent SCD genotypes, were included. All individuals underwent a full ophthalmologic examination (with a fundoscopy), a spectral domain ocular coherence tomography (SD-OCT) and a mfERG.
RESULTS: A total of 86 subjects were included: 54 SCD patients (107 eyes) with 32 HbSS (63 eyes) and 22 HbSC (44 eyes) and 32 controls (64 eyes). None of the eyes showed retinal clinical abnormalities. SD-OCT analysis showed that macular thickness was statistically lower in SCD eyes than in controls. mfERG analysis demonstrated a significant reduction of N1 (initial-negative deflection), and P1 (positive peak) response amplitude densities of HbSS eyes compared to HbAA eyes from the centre (<2°) and to the periphery (>15°). Implicit time response was also reduced in the centre (<2°). N1 and P1 response amplitude densities of HbSC eyes were significantly lower than those of HbAA eyes from the centre (<2°) to the periphery (>15°). N1 implicit time was statistically reduced in HbSS compared to HbSC eyes.
CONCLUSION: Our study is the first one to describe macular electrophysiological dysfunction in SCD patients. Moreover, we confirm that SCD maculopathy is equally frequent in HbSS and HbSC.

Entities:  

Year:  2019        PMID: 31289356      PMCID: PMC7002728          DOI: 10.1038/s41433-019-0499-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  32 in total

1.  [Recovery of sickle cell disease ischemic maculopathy after erythropheresis: a clinical case study].

Authors:  N Leveziel; O Kirsch; M Lautier-Frau; F Driss; H Offret; M Labetoulle
Journal:  J Fr Ophtalmol       Date:  2005-06       Impact factor: 0.818

2.  Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy.

Authors:  Xuejing Chen; Ehsan Rahimy; Robert C Sergott; Renata P Nunes; Eduardo C Souza; Netan Choudhry; Nathan E Cutler; Samuel K S Houston; Marion R Munk; Amani A Fawzi; Sonia Mehta; Jean-Pierre Hubschman; Allen C Ho; David Sarraf
Journal:  Am J Ophthalmol       Date:  2015-04-04       Impact factor: 5.258

3.  Paracentral acute middle maculopathy in sickle cell disease.

Authors:  Tomas Ilginis; Pearse A Keane; Adnan Tufail
Journal:  JAMA Ophthalmol       Date:  2015-05       Impact factor: 7.389

4.  Evaluation of Macular Vascular Abnormalities Identified by Optical Coherence Tomography Angiography in Sickle Cell Disease.

Authors:  Ian C Han; Mongkol Tadarati; Katia D Pacheco; Adrienne W Scott
Journal:  Am J Ophthalmol       Date:  2017-02-14       Impact factor: 5.258

Review 5.  Sickle cell disease.

Authors:  Russell E Ware; Mariane de Montalembert; Léon Tshilolo; Miguel R Abboud
Journal:  Lancet       Date:  2017-02-01       Impact factor: 79.321

6.  SPECTRAL DOMAIN VERSUS SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE RETINAL CAPILLARY PLEXUSES IN SICKLE CELL MACULOPATHY.

Authors:  Jesse J Jung; Michael H Chen; Caroline R Frambach; Soraya Rofagha; Scott S Lee
Journal:  Retin Cases Brief Rep       Date:  2018 Spring

Review 7.  Assessing retinal function with the multifocal technique.

Authors:  D C Hood
Journal:  Prog Retin Eye Res       Date:  2000-09       Impact factor: 21.198

8.  Spectral domain optical coherence tomography in patients with sickle cell disease.

Authors:  Raeba Mathew; Rinoza Bafiq; Jayashree Ramu; Elizabeth Pearce; Matthew Richardson; Emma Drasar; Swee Lay Thein; Sobha Sivaprasad
Journal:  Br J Ophthalmol       Date:  2015-01-16       Impact factor: 4.638

9.  Blood rheological abnormalities in sickle cell anemia.

Authors:  Philippe Connes; Céline Renoux; Marc Romana; Manouk Abkarian; Philippe Joly; Cyril Martin; Marie-Dominique Hardy-Dessources; Samir K Ballas
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

10.  Effect of Age on Blood Rheology in Sickle Cell Anaemia and Sickle Cell Haemoglobin C Disease: A Cross-Sectional Study.

Authors:  Céline Renoux; Marc Romana; Philippe Joly; Séverine Ferdinand; Camille Faes; Nathalie Lemonne; Sarah Skinner; Nathalie Garnier; Maryse Etienne-Julan; Yves Bertrand; Marie Petras; Giovanna Cannas; Lydia Divialle-Doumdo; Elie Nader; Daniela Cuzzubbo; Yann Lamarre; Alexandra Gauthier; Xavier Waltz; Kamila Kebaili; Cyril Martin; Arnaud Hot; Marie-Dominique Hardy-Dessources; Vincent Pialoux; Philippe Connes
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

View more
  1 in total

Review 1.  [Maculopathy in sickle cell disease].

Authors:  Isabel Bachmeier; Christiane Blecha; Jürgen Föll; Daniel Wolff; Herbert Jägle
Journal:  Ophthalmologe       Date:  2021-01-27       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.